Does LEUPROLIDE Cause Metastases to bone? 848 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 848 reports of Metastases to bone have been filed in association with LEUPROLIDE (Fensolvi). This represents 1.2% of all adverse event reports for LEUPROLIDE.
848
Reports of Metastases to bone with LEUPROLIDE
1.2%
of all LEUPROLIDE reports
154
Deaths
168
Hospitalizations
How Dangerous Is Metastases to bone From LEUPROLIDE?
Of the 848 reports, 154 (18.2%) resulted in death, 168 (19.8%) required hospitalization, and 9 (1.1%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 848 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
CAPECITABINE (763)
Which LEUPROLIDE Alternatives Have Lower Metastases to bone Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM